Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1993 Nov;69(5):550–554. doi: 10.1136/adc.69.5.550

Remission death in acute lymphoblastic leukaemia: a changing pattern.

A Atra 1, S M Richards 1, J M Chessells 1
PMCID: PMC1029616  PMID: 8257173

Abstract

The pattern of remission deaths was examined in 842 children with acute lymphoblastic leukaemia (ALL) treated at a single centre over 18 years. The mortality rate from leukaemia fell significantly during three consecutive time periods during which treatment became progressively more intensive and that during remission induction fell from 3.5% to under 1%, but the rate of death in remission stayed constant at 5-6%. The factors associated with an increased risk of remission death were: young age, a higher leucocyte count, bone marrow transplantation, and Down's syndrome. The pattern of remission deaths changed over the years; measles and herpes viruses decreased while deaths associated with periods of intensification and gut toxicity increased. Four children developed second neoplasms. Treatment of ALL is still associated with a significant risk of death in remission but the pattern of infective deaths has changed. Many should be avoidable by provision of adequate supportive care, close supervision after periods of intensive treatment, and appropriate antibiotic, antifungal, and cytokine therapy.

Full text

PDF
551

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Annerén G., Magnusson C. G., Lilja G., Nordvall S. L. Abnormal serum IgG subclass pattern in children with Down's syndrome. Arch Dis Child. 1992 May;67(5):628–631. doi: 10.1136/adc.67.5.628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aricò M., Comelli A., Bossi G., Raiteri E., Piombo M., Egeler R. M. Langerhans cell histiocytosis and acute leukemia: unusual association in two cases. Med Pediatr Oncol. 1993;21(4):271–273. doi: 10.1002/mpo.2950210407. [DOI] [PubMed] [Google Scholar]
  3. Chessells J. M., Bailey C., Wheeler K., Richards S. M. Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X. Lancet. 1992 Sep 5;340(8819):565–568. doi: 10.1016/0140-6736(92)92103-m. [DOI] [PubMed] [Google Scholar]
  4. Chessells J. M., Leiper A. D. Infection during remission induction in childhood leukaemia. Arch Dis Child. 1980 Feb;55(2):118–123. doi: 10.1136/adc.55.2.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chessells J. M., Leiper A. D., Tiedemann K., Hardisty R. M., Richards S. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia. Arch Dis Child. 1987 Feb;62(2):172–176. doi: 10.1136/adc.62.2.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Egeler R. M., Neglia J. P., Puccetti D. M., Brennan C. A., Nesbit M. E. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer. 1993 Feb 1;71(3):865–873. doi: 10.1002/1097-0142(19930201)71:3<865::aid-cncr2820710334>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  7. Haron E., Feld R., Tuffnell P., Patterson B., Hasselback R., Matlow A. Hepatic candidiasis: an increasing problem in immunocompromised patients. Am J Med. 1987 Jul;83(1):17–26. doi: 10.1016/0002-9343(87)90492-x. [DOI] [PubMed] [Google Scholar]
  8. Levitt G. A., Stiller C. A., Chessells J. M. Prognosis of Down's syndrome with acute leukaemia. Arch Dis Child. 1990 Feb;65(2):212–216. doi: 10.1136/adc.65.2.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Masur H. Prevention and treatment of pneumocystis pneumonia. N Engl J Med. 1992 Dec 24;327(26):1853–1860. doi: 10.1056/NEJM199212243272606. [DOI] [PubMed] [Google Scholar]
  10. Mott M. G., Chessells J. M., Willoughby M. L., Mann J. R., Morris-Jones P. H., Malpas J. S., Palmer M. K. Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG). Br J Cancer. 1984 Oct;50(4):457–462. doi: 10.1038/bjc.1984.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nash K. A., Mohammed G., Nandapalan N., Kernahan J., Scott R., Craft A. W., Toms G. L. T cell function in children with acute lymphoblastic leukaemia. Br J Haematol. 1993 Mar;83(3):419–427. doi: 10.1111/j.1365-2141.1993.tb04666.x. [DOI] [PubMed] [Google Scholar]
  12. Neglia J. P., Meadows A. T., Robison L. L., Kim T. H., Newton W. A., Ruymann F. B., Sather H. N., Hammond G. D. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med. 1991 Nov 7;325(19):1330–1336. doi: 10.1056/NEJM199111073251902. [DOI] [PubMed] [Google Scholar]
  13. Ninane J., Chessells J. M. Serious infections during continuing treatment of acute lymphoblastic leukaemia. Arch Dis Child. 1981 Nov;56(11):841–844. doi: 10.1136/adc.56.11.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pinkerton C. R., Bowman A., Holtzel H., Chessells J. M. Intensive consolidation chemotherapy for acute lymphoblastic leukaemia (UKALL X pilot study). Arch Dis Child. 1987 Jan;62(1):12–18. doi: 10.1136/adc.62.1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pui C. H., Ribeiro R. C., Hancock M. L., Rivera G. K., Evans W. E., Raimondi S. C., Head D. R., Behm F. G., Mahmoud M. H., Sandlund J. T. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med. 1991 Dec 12;325(24):1682–1687. doi: 10.1056/NEJM199112123252402. [DOI] [PubMed] [Google Scholar]
  17. Rapson N. T., Cornbleet M. A., Chessells J. M., Bennett A. J., Hardisty R. M. Immunosuppression and serious infections in children with acute lymphoblastic leukaemia: a comparison of three chemotherapy regimes. Br J Haematol. 1980 May;45(1):41–52. doi: 10.1111/j.1365-2141.1980.tb03809.x. [DOI] [PubMed] [Google Scholar]
  18. Reaman G. H., Steinherz P. G., Gaynon P. S., Bleyer W. A., Finklestein J. Z., Evans R., Miller D. R., Sather H. N., Hammond G. D. Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Cancer Treat Rep. 1987 Nov;71(11):1033–1038. [PubMed] [Google Scholar]
  19. Viscoli C., Castagnola E., Rogers D. Infections in the compromised child. Baillieres Clin Haematol. 1991 Apr;4(2):511–543. doi: 10.1016/s0950-3536(05)80169-6. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES